Our clinic has recently started offering the Lymphocyte T-Cell Immunomodulator FeLV and FIV treatment to our clients with cats suffering from Feline Leukemia (FeLV) and Feline Aids (FIV).
The Lymphocyte T-Cell Immunomodulator FeLV and FIV treatment is a USDA-approved treatment for FeLV and FIV and the associated symptoms of:
- Opportunistic Infection
How Lymphocyte T-Cell Immunomodulator FeLV and FIV Treatment Works
Lymphocyte T-Cell Immunomodulator is a naturally-occurring, immune-modulating protein that will help to restore a cat’s ability to fight infection.
This injection eliminates impaired CD4 lymphocytes (infection-fighting, specialized white blood cells) and allows new, normal CD4s to produce the cytokines involved in increasing CD8 populations (the “killer” cells that go to infection sites, gobble up bacteria, find and destroy viruses in the body, and knock out cancer cells) resulting in normalization of blood parameters and resolution of opportunistic infections.
Lymphocyte T-Cell Immunomodulator may not be a cure for FeLV or FIV, but when effective, it aids in the treatment of these deadly diseases by restoring (modulating) your cat’s normal immune system.
How Lymphocyte T-Cell Immunomodulator FeLV and FIV Treatment is Administered
Lymphocyte T-Cell Immunomodulator is administered by a veterinarian with a simple, painless injection under your cat’s skin.
The loading dose is three injections scheduled one week apart (days 0, 7, and 14). Afterwards, it is administered at the veterinarian’s discretion either monthly or bi-monthly, or as needed. Sometimes critically ill patients are treated with a more aggressive treatment schedule.
- Induction of T-cell maturation by a cloned line of thymic epithelium (TEPI)
- Immunologic Effects of Human Thymic Stromal Grafts and Cell Lines
- Lymphocyte T-Cell Immunomodulator (LTCI): Review of the Immunopharmocology of a New Veterinary Biologic
Source: T-Cyte Therapeutics